Raising the Bar in HR+/HER2- Early Breast Cancer: CDK4 and 6 Inhibitors
20:17
Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and Toxicity
49:04
Advancing Therapeutic Control in Desmoid Tumors
26:08
Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference
55:14
The Cerebellum in Cognition, Development and Disorders with Anila D'Mello, PhD
52:18
¿UNA DIETA PUEDE CURAR EL CÁNCER?
26:40
CDK 4/6 inhibition in early breast cancer By Dr. Ahmed Saadeddin 18-6-2021 (Day1)
11:42
CDK4 6 Inhibitors: Changing the Early Breast Cancer Landscape
7:59